| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/30/1998 | US5773612 Indol-2-one derivatives |
| 06/30/1998 | US5773530 Pyrazolopyridine adenosine antagonists |
| 06/30/1998 | US5773463 Decalcification of brain disorders |
| 06/30/1998 | US5773452 Alzheimer's disease; cognition activators |
| 06/30/1998 | US5773451 Bactericides for helicobacter bacteria |
| 06/30/1998 | US5773450 Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles |
| 06/30/1998 | US5773448 Nervous system disorders |
| 06/30/1998 | US5773440 Antiinflammatory agent |
| 06/30/1998 | US5773439 Nervous system disorders |
| 06/30/1998 | US5773436 Use of serotonin antagonists for treating fibromyalgia |
| 06/30/1998 | US5773433 Substituted tetracyclic oxazepine and thiazepine derivatives |
| 06/30/1998 | US5773414 Endothelin antagonists |
| 06/30/1998 | US5773031 Acetaminophen sustained-release formulation |
| 06/30/1998 | US5773003 Can be administered to a mammal to elicit antihapten antibodies that are capable of binding and neutralizing hapten at site of entry into body |
| 06/30/1998 | CA2239926A1 N-linked sulfonamides of heterocyclic thioesters |
| 06/30/1998 | CA2139947C Calcium channel blocking polypeptide from agelenopsis aperta |
| 06/27/1998 | CA2225906A1 3-deoxyglucosone production inhibitor |
| 06/25/1998 | WO1998027206A2 POLYPEPTIDES OF THE 'BASIC-HELIX-LOOP-HELIX' bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES |
| 06/25/1998 | WO1998027202A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 06/25/1998 | WO1998027113A2 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 06/25/1998 | WO1998027081A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 06/25/1998 | WO1998027066A1 Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors |
| 06/25/1998 | WO1998027058A2 N-piperazin-1-ylphenyl-benzamide derivatives |
| 06/25/1998 | WO1998027055A1 Aminoindan derivatives |
| 06/25/1998 | WO1998026782A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications |
| 06/25/1998 | WO1998026780A2 Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same |
| 06/25/1998 | WO1998026775A1 Phenylethylamine derivatives |
| 06/25/1998 | WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 06/25/1998 | WO1998026770A2 The topical use of kappa opioid agonists to treat ocular pain |
| 06/25/1998 | WO1998026763A1 Active substance carrier for releasing apomorphine into the buccal cavity |
| 06/25/1998 | WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 06/25/1998 | WO1998012190A3 Phenoxathiin derivatives as inhibitors of monoamine oxidase |
| 06/25/1998 | CA2275492A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 06/25/1998 | CA2275454A1 Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences |
| 06/25/1998 | CA2275442A1 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 06/25/1998 | CA2274893A1 Active substance carrier for releasing apomorphine into the buccal cavity |
| 06/25/1998 | CA2274807A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses |
| 06/25/1998 | CA2274055A1 N-piperazin-1-ylphenyl-benzamide derivatives |
| 06/25/1998 | CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 06/24/1998 | EP0849361A2 Novel ligands of the neuropeptide receptor HFGAN72 |
| 06/24/1998 | EP0849263A2 Pharmaceutical substituted propanoic acid derivatives |
| 06/24/1998 | EP0848955A1 Anti-stress agent for animals comprising an ascorbic acid derivative |
| 06/24/1998 | EP0848736A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 06/24/1998 | EP0848707A1 4-(cycloalkyl)piperidines and 4-(cycloalkylalkyl)-piperidines derivatives, preparation thereof and therapeutical applications thereof |
| 06/24/1998 | EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
| 06/24/1998 | EP0848592A1 Antistress agents for aquatic animals |
| 06/24/1998 | EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same |
| 06/24/1998 | CN1185742A Protein kinase c inhibitors |
| 06/24/1998 | CN1185319A Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/24/1998 | CN1185317A 丁丙诺啡经皮吸收剂 Buprenorphine percutaneous absorption |
| 06/24/1998 | CN1038840C Para-dinitrogen naphthalene derivative, its preparation method and medical use |
| 06/23/1998 | US5770740 Treating depression and obsessive compulsive disorders |
| 06/23/1998 | US5770624 Inhibitors of tumor necrosis factor alpha and matrix degrading metalloproteinease activity |
| 06/23/1998 | US5770612 Administering substituted benzothiophenes, solvates or salts along with analgesics, diuratics or antihistaminesalong with |
| 06/23/1998 | US5770611 Indole derivatives as 5HT1 -like agonists |
| 06/23/1998 | US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 06/23/1998 | US5770573 CS-1 peptidomimetics, compositions and methods of using the same |
| 06/23/1998 | US5770571 Method and agents for inhibiting protein aging |
| 06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
| 06/23/1998 | US5770567 Sensory and motor neuron derived factor (SMDF) |
| 06/23/1998 | US5770455 Identifier tag which is a microchip that is pre-encoded or encodable with information that is related back to a detector when the tag is pulsed with electromagnetic radiation |
| 06/23/1998 | US5770233 Container filled with infusion liquids and infusion preparation |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
| 06/20/1998 | CA2225273A1 Vitronectin receptor antagonists, their preparation and their use |
| 06/18/1998 | WO1998026069A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026062A2 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 06/18/1998 | WO1998026047A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025950A1 Polyprolyl inhibitors of cyclophilin |
| 06/18/1998 | WO1998025920A1 3-pyridyl enantiomers and their use as analgesics |
| 06/18/1998 | WO1998025914A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 06/18/1998 | WO1998025904A1 Diphenyl alkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them |
| 06/18/1998 | WO1998025903A1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 06/18/1998 | WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 06/18/1998 | WO1998025899A1 Novel heterocyclically substituted benzamides and their use in fighting diseases |
| 06/18/1998 | WO1998025883A1 Ketobenzamides as calpain inhibitors |
| 06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 06/18/1998 | WO1998025640A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 06/18/1998 | WO1998025627A1 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT |
| 06/18/1998 | WO1998025626A1 Use of equilenin as an antioxidant |
| 06/18/1998 | WO1998025625A1 USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 06/18/1998 | WO1998025616A1 Leukotriene antagonists for cerebral focal stroke |
| 06/18/1998 | WO1998025615A1 Leukotriene antagonists for oral squamous cell carcinoma |
| 06/18/1998 | WO1998025606A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents |
| 06/18/1998 | WO1998025594A2 Lamotrigine in the treatment and prophylaxis of migraine |
| 06/18/1998 | WO1998025588A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 06/18/1998 | WO1998018919A3 GABAa Receptor subunit epsilon-related protein |
| 06/18/1998 | DE19652268A1 Wirkstoffträger für die Freisetzung von Apomorphin in der Mundhöhle Drug carrier for release of apomorphine in the oral cavity |
| 06/18/1998 | DE19652188A1 Flache Arzneizubereitung zur Applikation und Freisetzung von Buprenorphin oder einer pharmakologisch vergleichbaren Substanz in der Mundhöhle und Verfahren zu ihrer Herstellung Flat pharmaceutical preparation for application and release of buprenorphine or a pharmacologically similar substance in the oral cavity and processes for their preparation |
| 06/18/1998 | CA2274908A1 Leukotriene antagonists for cerebral focal stroke |
| 06/18/1998 | CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 06/18/1998 | CA2274858A1 Novel treatment |
| 06/18/1998 | CA2274855A1 Leukotriene antagonists for oral squamous cell carcinoma |
| 06/18/1998 | CA2274839A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |